Hypothesis: The recent decline in coronary heart disease mortality - Mainly a shift from fatal to non-fatal events?

Scandinavian Cardiovascular Journal

Volumn 34, Issue 5, 2000, Pages 468-474

  Erikssen, Gunnar ^a   Liest, Knut ^b   Bjonholt, Jogen Vildersho ^c   Thaulow, Erik ^a   Erikssen, Jan ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b Institute for Informatics   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Coronary heart disease mortality; Disease progression; Follow up studies; Healthy middle aged men; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN; NITRIC ACID DERIVATIVE; STATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FATALITY; FOLLOW UP; HEALTH STATUS; HEART DEATH; HEART INFARCTION; HUMAN; HYPOTHESIS; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORBIDITY; NORWAY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 17744362656     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/140174300750064620     Document Type: Article

References (26)

1. Vartainen E, Puska P, Pekkanen J, et al. Changes in risk-factors explain changes in mortality from ischaemie heart disease in Finland. Br Med J 1994; 309: 23-27.
2. Rosamond WD, Chambless LE, Folsom AR. Survival trends, coronary event rates, and the MONICA project. Lancet 1999; 354: 862-865.
3. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-867.
4. Tunstall-Pedhoe H, Kuulasmaa K, Mähönen M, et al. Contributions of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet 1999; 353: 1547-1557.
5. Levy D, Thorn T. Death rates from coronary disease - progress and a puzzling paradox. N Engl J Med 1998; 339: 915-916.
6. Grover SA. Role of WHO-MONICA project in unravelling of the cardiovascular puzzle. Lancet 2000; 355: 668-669.
7. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990; 322: 1635-1641.
8. Erikssen G, Liest01 K, Bj0rnholt JV, et al. Changes in physical fitness and changes in mortality. Lancet 1998; 352: 759-762.
9. Erikssen J Aspects of latent coronary heart disease: a prevalence and methodological validation study of apparently healthy, working, middle-aged men. PhD thesis. University Hospital (Rikshospitalet), Medical Department B, Oslo, Norway, 1978.
10. Erikssen J, Mundal R. The non-infarct patient with coronary artery disease: can a high risk group be identified? Ann NY Acad Sei 1982; 382: 438-449.
11. Sandvik L, Erikssen G, Thaulow E. Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle-aged Norwegian men for seven years. Br Med J 1995; 311: 715-718.
12. Erikssen G, Liest01 K, Bj0rnholt JV, et al. Erythrocyte sedimentation rate - a possible marker of atherosclerosis and a strong predictor of coronary heart disease (CHD) mortality. Eur Heart J 2000; 21: 1614-20.
13. Sandvik L, Erikssen J, Thaulow E, et al. Heart volume and cardiovascular mortality. A 16-year follow-up study of 1984 healthy middle-aged men. Eur Heart J 1993; 14: 592-6.
14. Statistics Norway 2000. Design, procedure and quality. In: Causes of death 1996. (ch 2).
15. Ebrahim S, Smith GD. Systematic review of randomized controlled trials of multiple risk factor interventions for preventing coronary heart disease. Br Med J 1997; 314: 1666-1674.
16. Stokes III J, Kännel WB, Wolf PA, et al. The relative importance of selected risk factors for manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987; 75 Suppl V: V65-V73.
17. Tunstall-Pedoe H, Woodward M, Tavendale R, et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. Br Med J 1997: 315: 722-729.
18. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996; 334: 884-890.
19. Parker JD. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary heart disease: an indication for clinical trials. Eur Heart J 1998; 19 Suppl I: 115-119.
20. Ridker PM, Cushman M, Stampffer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med; 1997; 336: 973-979.
21. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air ForceAexas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622.
22. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
23. Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980-90. The effects of secular trends in risk factors and treatment. JAMA 1997; 277: 535-542.
24. Salomaa V, Miettinen H, Kuulasmaa K, et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The F1NMONICA MI Register Study. Circulation 1996; 94: 3130-3137.
25. Tunstall-Pedhoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000; 355: 688-700.
26. Salomaa V, Rosamond W, Mähönen M. Decreasing mortality from acute myocardial infarction: effect of incidence and prognosis. J Cardiovasc Risk 1999; 6: 69-75.